B-Cell Lymphoblastic Leukemia Monitoring for Minimal Residual Disease: Min Shi, M.D., Ph.D.

(00:45) Could you just provide our listeners with a little bit of information about you and your background?  (01:00) The laboratory recently made some updates to this testing for minimal residual disease. Can you just give us a brief overview of that assay? (03:22) So these patients go through these treatments, and at what point do they really need this testing, or when should it be considered by clinicians to perform it? (05:18) What brought the laboratory to flow cytometry for this MRD test for this particular disease state? Why did we not choose those other methods? (09:44) So hearing you talk about how this test is serving the entire patient population, how are these results for this minimal residual disease test used for patient care?